BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sanyal AJ. The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep. 2000;2:61-71. [PMID: 10981005 DOI: 10.1007/s11894-000-0053-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kircheis G, Bode JG, Hilger N, Kramer T, Schnitzler A, Häussinger D. Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation. Eur J Gastroenterol Hepatol. 2009;21:1383-1394. [PMID: 19738480 DOI: 10.1097/MEG.0b013e328310e0c3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
2 Habib A, Sanyal AJ. Acute Variceal Hemorrhage. Gastrointest Endosc Clin N Am. 2007;17:223-252. [PMID: 17556146 DOI: 10.1016/j.giec.2007.03.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
3 Paramesh AS, Husain SZ, Shneider B, Guller J, Tokat I, Gondolesi GE, Moyer S, Emre S. Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature. Pediatr Transplant. 2003;7:157-162. [PMID: 12654059 DOI: 10.1034/j.1399-3046.2003.00033.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
4 Trotter JF. Coagulation Abnormalities in Patients Who Have Liver Disease. Clinics in Liver Disease 2006;10:665-78. [DOI: 10.1016/j.cld.2006.08.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
5 Garcia N, Mihas AA. Hepatic hydrothorax: pathophysiology, diagnosis, and management. J Clin Gastroenterol. 2004;38:52-58. [PMID: 14679328 DOI: 10.1097/00004836-200401000-00012] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
6 Aref S, Ibrahem L, El Menshawy N, Bassam A. Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia. Hematology 2012;17:118-21. [PMID: 22664051 DOI: 10.1179/102453312X13221316477705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Roussos A, Philippou N, Mantzaris GJ, Gourgouliannis KI. Hepatic hydrothorax: pathophysiology diagnosis and management. J Gastroenterol Hepatol. 2007;22:1388-1393. [PMID: 17645471 DOI: 10.1111/j.1440-1746.2007.05069.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
8 Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003;52:879-885. [PMID: 12740346 DOI: 10.1136/gut.52.6.879] [Cited by in Crossref: 188] [Cited by in F6Publishing: 177] [Article Influence: 10.4] [Reference Citation Analysis]
9 Shin ES, Darcy MD. Transjugular intrahepatic portosystemic shunt placement in the setting of polycystic liver disease: questioning the contraindication. J Vasc Interv Radiol 2001;12:1099-102. [PMID: 11535774 DOI: 10.1016/s1051-0443(07)61598-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
10 Angermayr B, Cejna M, Schoder M, Wrba F, Valent P, Gangl A, Peck-Radosavljevic M. Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis. Blood 2002;99:4246-7. [PMID: 12043694 DOI: 10.1182/blood-2002-01-0282] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
11 Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, Gangl A, Peck-radosavljevic M; for the Vienna TIPS Study Group. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology 2003;38:1043-50. [DOI: 10.1002/hep.1840380431] [Cited by in Crossref: 76] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
12 Bernts LHP, Drenth JPH, Tjwa ETTL. Management of portal hypertension and ascites in polycystic liver disease. Liver Int. 2019;39:2024-2033. [PMID: 31505092 DOI: 10.1111/liv.14245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol 2006; 12(8): 1205-1210 [PMID: 16534872 DOI: 10.3748/wjg.v12.i8.1205] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
14 Jiang ZB, Shan H, Shen XY, Huang MS, Li ZR, Zhu KS, Guan SH. Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis. World J Gastroenterol 2004; 10(13): 1881-1884 [PMID: 15222028 DOI: 10.3748/wjg.v10.i13.1881] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
15 Therapondos G, Wong F. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt: . European Journal of Gastroenterology & Hepatology. [DOI: 10.1097/01.meg.0000236876.60354.25] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
16 Arnold HL, Harrison SA. New advances in evaluation and management of patients with polycystic liver disease. Am J Gastroenterol. 2005;100:2569-2582. [PMID: 16279915 DOI: 10.1111/j.1572-0241.2005.00263.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
17 Zhao H, Liu F, Yue Z, Wang L, Fan Z, He F. Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome. Medicine (Baltimore). 2017;96:e9080. [PMID: 29245324 DOI: 10.1097/md.0000000000009080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Mihas AA, Sanyal AJ. Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology 2004;127:621-9. [DOI: 10.1053/j.gastro.2004.05.060] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
19 McCashland TM. Current use of transjugular intrahepatic portosystemic shunts. Curr Gastroenterol Rep. 2003;5:31-38. [PMID: 12530946 DOI: 10.1007/s11894-003-0007-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]